The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
One that I just would like to reference the last name of the first author is Mahdavi M-A-H-D-A-V-I. The title of the paper is Effects of l -Carnitine Supplementation on Serum Inflammatory Markers and Matrix Metalloproteinases Enzymes in Females with Knee Osteoarthritis. So this is a randomized double blind placebo controlled pilot study that showed really interesting effects of short term supplementation of acetylcarnitine. Longer term, the effects were less impressive.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.